Antibiotic resistance in patients with primary immunodeficiency disorders and the potential use of polyvalent immunoglobulins in modulating innate immune cells and in countering antibiotic resistance

Anno
2017
Proponente Isabella Quinti - Professore Ordinario
Sottosettore ERC del proponente del progetto
Componenti gruppo di ricerca
Componente Categoria
Cinzia Milito Dottorando/Assegnista/Specializzando componente il gruppo di ricerca
Metello Iacobini Componenti il gruppo di ricerca
Componente Qualifica Struttura Categoria
Annalisa Pantosti dirigente Laboratorio Malattie Batteriche, Respiratorie e Sistemiche Istituto Superiore di Sanità Altro personale Sapienza o esterni
Marina Cerquetti ricercatore Dipartimento di Malattie infettive, parassitarie ed immunomediate Istituto Superiore di Saniota Altro personale Sapienza o esterni
Alessandro Prezzo borsista Dip Medicina Molecolkare Altro personale Sapienza o esterni
Abstract

For PID patients, as well as for the general population, antibiotic resistance has become a serious problem for the risk of a significant failure of treatment necessary to control the infections that represent the most important morbidity and mortality factor in PID. Since no previous study has investigated the spectrum of antibiotic resistance among patients with PID, we propose to investigate: 1) bacterial colonization of the proximal airways; 2) the antibiotic sensitivity of microorganisms in PID patients treated for a long period of time with antibiotic prophylaxis 3) monocyte and neutrophils functions when exposed to isolated colonizing microorganisms, 4) immunoglobulins effect on the killing activity of patients' PMN/monocyte when exposed to sensitive or multidrug-resistant bacteria isolated from their throat. Nasopharyngeal swabs will be obtained from PIDs patients. The rate of sensitive and multi drug resistant S. pneumoniae and H. influenzae will be investigated. Moreover, since additional risk factor for infections in PIDs are the alterations of the innate immune system, which involve a set of cells and mechanisms involved in the host defence by a nonspecific and fast response and since many pathogens have evolved efficient strategies to evade chemotaxis, phagocytosis, and killing, we plan to evaluate PMN and monocyte activity after stimulation with sensitive and multi-drug resistant H. influenzae and S. pneumoniae isolated from PIDs. We will take advantage of the recently settled randomized, double arm study to evaluate the efficacy and safety of azithromycin for the long term prophylactic treatment of primary antibody deficiency coordinated by our group. Beside the possible beneficial effect of antibiotic prophylaxis we should verify if the prolonged use of these drugs might be associated with emergence of clinically significant bacterial resistance or immunosuppression.

ERC
Keywords:
name

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma